Nicotina y Derivados de Nicotina

Stability Hygroscopic
Applications rac-Cotinine-d3 N-β-D-Glucuronide is a labelled racemic analogue of Cotinine N-β-D-Glucuronide (C725175), a major metabolite of Nicotine (N412420) in humans. Carcinogen.
References Benowitz, N., et al.: Clin. Pharmacol. Ther., 56, 483 (1994), Nakajima, M., et al.: Drug Metab. Dispos., 24, 1212 (1996), Messina, E., et al.: J. Pharmacol. Exp. Ther., 282, 1608 (1997), Oscarson, M., et al.: Hum. Mutat., 20, 275 (2002),

Applications (S)-1-Methylnicotinium Iodide exhibits antinociceptive activity. A nicotinic receptor antagonist and a metabolite of Nicotine.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Aceto, M. D., et al.: Br. J. Pharmacol., 79, 869-876 (1983); Wilkins, L. H., et al.: J. Pharm. Exp. Ther., 304, 400-410 (2003); Seeman, J.I. and Whidby, J.F.: J. Org. Chem., 41, 24, 3824 (1976), Oldendorf, W.H., et al.: Proc. Natl. Acad. Sci., USA, 90, 307 (1993)

Applications (R)-Anabasine is a minor tobacco alkaloid from Nicotiana tabacum that is known to have nicotinic receptor agonist activity.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Lee, S.T., et al.: Neurotoxicol. Teratol., 28, 220 (2006); Ayers, J.T., et al.: AAPS J., 4, E752 (2005)

Stability Light Sensitive
Applications (±)-Nicotine-d7 (N-methyl-d3; pyridine-d4) is the labelled version of Nicotine (N412420(M)) is an alkaloid isolated from plants. Nicotine is an active stimulant, having both addictive and carcinogenic properties. Nicotine can be absorbed through the alimentary canal, respiratory tract and intact skin. Nicotine is used in the treatment of smoking withdrawal syndrome. Nicotine has been used as an anthelmintic.
References Ferretti, G., et al.: J. Med. Chem., 45, 4724 (2002), Guillen, M., et al.: J. Agric. Food Chem., 53, 1093 (2005), Ramunno, A., et al.: Bioorg. Med. Chem. Lett., 15, 3237 (2005), Alburges, M., et al.: Eur. J. Pharmacol., 573, 124 (2007),

Impurity Nicotine USP Related Compound F (3-(pyrrolidine-2-yl)pyridine)
Stability Light Sensitive
Applications (RS)-Nornicotine is a tobacco alkaloid and the major Nicotine (N412420) metabolite in brain. Nornicotine appears to activate different nAChR subtypes, has a better pharmacokinetic profile, and produces less toxicity than Nicotine. Nornicotine shows a significant analgesic activity. Nicotine USP Related Compound F (3-(pyrrolidine-2-yl)pyridine).
References Hecht, S., et al.: Carcinogenesis, 9, 875 (1988), Rivenson, A., et al.: Cancer Res., 48, 6912 (1988), Hoffmann, D., et al.: Chem. Res. Toxicol., 14, 767 (2001), Kool, J., et al.: J. Med. Chem., 49, 3287 (2006), Kool, J., et al.: Drug Metab. Dispos., 35, 640 (2007),

Applications Nicotine Salicylate is used for treatment of smoking withdrawal syndrome.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Eneroth, P., et al.: Med. Biol., 55, 158 (1977),

Applications Trigonelline (chloride) is an alkaloid found in plants and coffee. Trigonelline is a product of niacin metabolism that is excreted in urine.

Applications Labelled rac-Nicotine (N412420). Nicotine is an alkaloid isolated from plants. Nicotine is an active stimulant, having both addictive and carcinogenic properties. Nicotine can be absorbed through the alimentary canal, respiratory tract and intact skin. Nicotine is used in the treatment of smoking withdrawal syndrome. Nicotine has been used as an anthelmintic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Guillen, M., et al.: J. Agric. Food Chem., 53, 1093 (2005), Alburges, M., et al.: Eur. J. Pharmacol., 573, 124 (2007), Roy, K., et al.: Eur. J. Med. Chem., 44, 1941 (2009),

Stability Hygroscopic
Applications (R,S)-Norcotinine-pyridyl-d4 (cas# 1020719-70-3) is a compound useful in organic synthesis.

Applications A nicotinic receptor agonist; brain rubidium efflux pharmacol.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Alkondon, M., et al.: J. Pharmacol. Exp. Ther., 271, 494 (1994); Wang, F., et al.: J. Biol. Chem., 271, 17656 (1996); Corringer, P., et al.: J. Neurosci., 18, 648 (1998);

Applications Labelled Nudifloramide (N925500). Nudifloramide is a metabolite of Niacin (or Nicorinic acid).
References Felsted, R., et al.: J. Biol. Chem., 242, 1274 (1967), Igel, M., et al.: Eur. J. Clin. Pharmacol., 57, 357 (2001), Kashyap, M., et al.: Am. J. Cardiol., 89, 672 (2002), Bottorff, M., et al.: Am. J. Cardiol., 97, 27 (2006),

Applications Labelled Nicotinamide, precursor of the coenzymes NAD and NADP. Nicotinamide is a water soluble vitamin (enzyme cofactor).
References Sharma, M., et al.: J. Chem. Pharm. Res., 2, 416 (2010); Al-Nadaf, A., et al.: Bioorg. Medi. Chem., 18, 3088 (2010);

Applications Prototype nicotinic acetylcholine receptor agonist; naturally occurring isomer. It is a potent neurotoxin.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Ferretti, G., et al.: J. Med. Chem., 45, 4724 (2002), Guillen, M., et al.: J. Agric. Food Chem., 53, 1093 (2005), Ramunno, A., et al.: Bioorg. Med. Chem. Lett., 15, 3237 (2005), Alburges, M., et al.: Eur. J. Pharmacol., 573, 124 (2007),

Applications 1-(3-Pyridyl)-1-butanol-4-carboxylic Acid Na+/NH4+ Salt is a metabolite of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (M325750), which is a major carcinogen, found in cigarette smoke.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hecht, S., et al.: Chem. Res. Toxicol., 11, 559 (1998); Hecht, S., et al.: Carcinogenesis, 23, 907 (2002); Sasco, A., et al.: Lung Cancer, 45, S3 (2004);

Applications A nicotinic receptor agonist; brain rubidium efflux pharmacol.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Alkondon, M., et al.: J. Pharmacol. Exp. Ther., 271, 494 (1994), Wang, F., et al.: J. Biol. Chem., 271, 17656 (1996), Corringer, P., et al.: J. Neurosci., 18, 648 (1998),